FDA Approves New Merkel Cell Carcinoma Drug Zynyz

México Noticias Noticias

FDA Approves New Merkel Cell Carcinoma Drug Zynyz
México Últimas Noticias,México Titulares
  • 📰 Medscape
  • ⏱ Reading Time:
  • 55 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 25%
  • Publisher: 55%

FDA approves new Merkel cell carcinoma drug zynyz. MedTwitter FDAapproves FDAAlert OncTwitter

was an open-label, single-arm, phase 2 study that evaluated the agent in 65 systemic treatment–naive adults with metastatic or recurrent locally advanced MCC.

Overall, 52% of patients had an objective response rate. A complete response was observed in 12 patients , and a partial response was observed in 22 patients . Duration of response ranged from 1.1 to 24.9 months; 76% of responders experienced responses of 6 months or longer, and 62% experienced responses of 12 months or longer.

Study participants received a 500-mg dose of retifanlimab every 4 weeks for up to 24 weeks or until disease progression or unacceptable toxicity. Serious adverse events occurred in 22% of patients and most often included fatigue, arrhythmia, and pneumonitis; 11% of patients discontinued treatment because of serious adverse events.

Retifanlimab may cause a severe or life-threatening immune response during treatment or after discontinuation. Patients should be advised to immediately report any new or worsening signs or symptoms to their healthcare provider. Side effects can also beSharon Worcester, MA, is an award-winning medical journalist based in Birmingham, Alabama, writing for Medscape, MDedge and other affiliate sites.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

Medscape /  🏆 386. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

FDA approves lab-grown ‘GOOD Meat’ chicken product, second such authorization in USFDA approves lab-grown ‘GOOD Meat’ chicken product, second such authorization in USThe US Food and Drug Administration (FDA) issued a “no questions” response to GOOD Meat, marking the company’s lab-grown chicken product safe to eat.
Leer más »

FDA approves lab-grown 'GOOD Meat' chicken product, second such authorization in USFDA approves lab-grown 'GOOD Meat' chicken product, second such authorization in USGOOD Meat's chicken is the second cultivated meat product to receive a 'no-questions' letter from the FDA, marking the company's lab-grown chicken product as safe to eat.
Leer más »

Cleveland City Council approves plans for new police HQCleveland City Council approves plans for new police HQCleveland City Council on Monday night approved Mayor Justin Bibb’s plan to renovate Superior Avenue’s historic ArtCraft building into Cleveland police’s new headquarters.
Leer más »

Amid a rise in fires and deaths, New York City enacts new e-bike rulesAmid a rise in fires and deaths, New York City enacts new e-bike rulesNYC Mayor Adams signed a package of e-bike safety legislation after 2022 saw 219 fires related to the devices.
Leer más »

'We heart New York': New slogan embraces city's bounce back from COVID-19'We heart New York': New slogan embraces city's bounce back from COVID-19The new slogan is a part of a campaign by Mayor Eric Adams.
Leer más »

Meet Utah's new state mushroom and its new state crustaceanMeet Utah's new state mushroom and its new state crustaceanUtah's two newest symbols recognize the vital roles each play in the state's ecosystem.
Leer más »



Render Time: 2025-03-01 10:16:24